BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24034056)

  • 1. Acute renal failure caused by hyperuremic acidemia in ABO-incompatible kidney transplant maintained with cyclosporine and high-dose mizoribine: a case report.
    Akioka K; Masuda K; Harada S; Nakamura T; Okugawa K; Nakano K; Osaka Y; Tsuchiya K; Sako H
    Transplant Proc; 2013 Sep; 45(7):2815-8. PubMed ID: 24034056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness and safety of high-dose mizoribine on ABO-incompatible living related kidney transplantation using anti-CD20 and anti-CD25 antibodies without splenectomy: 3-year results.
    Yoshimura N; Ushigome H; Nobori S; Suzuki T; Sakai K; Koshino K; Nakamura T; Nakao T; Harada S; Ito T
    Transplant Proc; 2014; 46(2):391-4. PubMed ID: 24655971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricemia and Acute Renal Failure in Renal Transplant Recipients Treated With High-Dose Mizoribine.
    Akioka K; Ishikawa T; Osaka M; Kadotani Y; Okugawa K; Nakano K; Osaka Y; Tsuchiya K; Sako H
    Transplant Proc; 2017; 49(1):73-77. PubMed ID: 28104163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
    Yoshimura N; Ushigome H; Matsuyama M; Nobori S; Suzuki T; Sakai K; Okajima H; Okamoto M
    Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial Effects of High-Dose Mizoribine on ABO-Incompatible Living-Related Kidney Transplantation: Two-Year Results by a Japanese Multicenter Study.
    Harada S; Nakamura T; Ushigome H; Akutsu N; Akioka K; Nakatani T; Yoshimura N
    Transplant Proc; 2017 Jun; 49(5):967-970. PubMed ID: 28583569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The excellent outcomes of ABO-incompatible kidney transplantation with high titer (>×2048) using anti-CD20 and anti-CD25 antibody without splenectomy: two case reports.
    Koshino K; Okamoto M; Sakai K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Okajima H; Yoshimura N
    Transplant Proc; 2011; 43(6):2379-82. PubMed ID: 21839272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent results of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids in renal transplant recipients--4-year results.
    Yoshimura N; Ushigome H; Nobori S; Suzuki T; Sakai K; Koshino K; Okajima H; Okamoto M
    Transplant Proc; 2013 May; 45(4):1472-5. PubMed ID: 23726600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of serum uric acid levels in response to the conversion from mycophenolate mofetil to mizoribine in kidney transplant recipients.
    Ding X; Zhu X; Zhang Y; Zhang L; Cheng M; Yu Y; Xu L; Li G
    Transplant Proc; 2013; 45(1):190-3. PubMed ID: 23375297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revival of effective and safe high-dose mizoribine for the kidney transplantation.
    Sugitani A; Kitada H; Ota M; Yoshida J; Doi A; Hirakata H; Tanaka M
    Clin Transplant; 2006; 20(5):590-5. PubMed ID: 16968484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation.
    Matsuo N; Yamamoto H; Kobayashi A; Yamamoto I; Mitome J; Maruyama Y; Hayakawa H; Miyazaki Y; Utsunomiya Y; Hosoya T; Yamaguchi Y
    Clin Transplant; 2009 Aug; 23 Suppl 20():23-6. PubMed ID: 19594591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of stable ABO-incompatible kidney transplant recipients from mycophenolate mofetil with standard exposure calcineurin inhibitors (CNIs) to everolimus with very low exposure CNIs-a short-term pilot study.
    Uchida J; Machida Y; Iwai T; Kuwabara N; Kabei K; Naganuma T; Kumada N; Kawashima H; Nakatani T
    Clin Transplant; 2014 Jan; 28(1):80-7. PubMed ID: 24329776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO-incompatible renal transplantation in Epstein syndrome.
    Ogura M; Kikuchi E; Kaito H; Kamei K; Matsuoka K; Tanaka H; Kuroda T; Sekine T; Ito S
    Clin Transplant; 2010 Jul; 24 Suppl 22():31-4. PubMed ID: 20590691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japanese experience of ABO-incompatible living kidney transplantation.
    Tanabe K
    Transplantation; 2007 Dec; 84(12 Suppl):S4-7. PubMed ID: 18162988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential value of high-dose mizoribine as rescue therapy for ongoing acute humoral rejection.
    Liu D; Kobayashi T; Nagasaka T; Yokoyama I; Ma Y; Miwa Y; Kuzuya T; Morozumi K; Oikawa T; Shimano Y; Takeuchi O; Uchida K; Nakao A
    Transpl Int; 2005 Apr; 18(4):401-7. PubMed ID: 15773958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations.
    Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N
    Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of follow-up biopsies at one year after ABO-incompatible kidney transplantation.
    Koshino K; Ushigome H; Nakao T; Harada S; Sakai K; Suzuki T; Nobori S; Ito T; Yoshimura N
    Transplant Proc; 2014; 46(2):385-7. PubMed ID: 24655969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial experience with ABO-incompatible live donor renal transplantation.
    Tsai MK; Wu MH; Lo SC; Lai IR; Yu SC; Yuan RH; Lee PH
    J Formos Med Assoc; 2006 Sep; 105(9):775-9. PubMed ID: 16959628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute allograft renal failure with marked hyperuricemia developing during mizoribine administration: a case report with review of the literature.
    Guo HB
    Transplant Proc; 2010 Sep; 42(7):2804-7. PubMed ID: 20832593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.